Ardelyx (ARDX) Operating Expenses (2013 - 2026)
Ardelyx (ARDX) posted Operating Expenses of $127.3 million for Q1 2026, down 14.47% on a QoQ basis from $148.8 million in Q4 2025, and up 15.21% year-over-year from $110.5 million in Q1 2025.
Ardelyx (ARDX) Operating Expenses (2013 - 2026) Analysis & Trends
Ardelyx's Operating Expenses history runs 14 years deep, the most recent figure standing at $127.3 million for Q1 2026.
- Quarterly Operating Expenses rose 15.21% year-over-year to $127.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $477.4 million (up 16.88% YoY) and the FY2025 annual result came in at $448.3 million, up 23.99% from the prior year.
- Operating Expenses was $127.3 million for Q1 2026 at Ardelyx, down from $148.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $148.8 million in Q4 2025 and bottomed at $26.1 million in Q3 2022.
- A 5-year average of $73.5 million and a median of $75.1 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses plunged 39.8% — and 2023, when it surged 159.99%.
- Ardelyx's Operating Expenses stood at $28.9 million in 2022, then jumped by 159.99% to $75.1 million in 2023, then soared by 86.89% to $140.3 million in 2024, then increased by 6.06% to $148.8 million in 2025, then fell by 14.47% to $127.3 million in 2026.
- Business Quant data shows ARDX's Operating Expenses at $127.3 million in Q1 2026, $148.8 million in Q4 2025, and $101.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | 127.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.27 Mn |
| Dec 31, 2025 | 148.80 Mn |
| Sep 30, 2025 | 101.68 Mn |
| Jun 30, 2025 | 99.65 Mn |
| Mar 31, 2025 | 110.46 Mn |
| Dec 31, 2024 | 140.30 Mn |
| Sep 30, 2024 | 80.28 Mn |
| Jun 30, 2024 | 77.42 Mn |
| Mar 31, 2024 | 63.57 Mn |
| Dec 31, 2023 | 75.07 Mn |
| Sep 30, 2023 | 41.30 Mn |
| Jun 30, 2023 | 35.47 Mn |
| Mar 31, 2023 | 35.90 Mn |
| Dec 31, 2022 | 28.87 Mn |
| Sep 30, 2022 | 26.13 Mn |
| Jun 30, 2022 | 28.60 Mn |
| Mar 31, 2022 | 28.28 Mn |
| Dec 31, 2021 | 35.30 Mn |
| Sep 30, 2021 | 43.41 Mn |
| Jun 30, 2021 | 46.15 Mn |